Zhao, Sizheng StevenJones, Gareth THughes, David MMoots, Robert JGoodson, Nicola J2021-12-102021-12-102021-12Zhao, S S, Jones, G T, Hughes, D M, Moots, R J & Goodson, N J 2021, 'Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis', Rheumatology, vol. 60, no. 12, pp. 5734–5742. https://doi.org/10.1093/rheumatology/keab2421462-0324ORCID: /0000-0003-0016-7591/work/93483281https://hdl.handle.net/2164/17659Acknowledgment We are grateful to Professor Gary Macfarlane for commenting on the manuscript. We are grateful to the staff of the BSRBR-AS register and to the recruiting staff at the clinical centres, details of which are available at: www.abdn.ac.uk/bsrbr-as. We also thank Dr Lewis Carpenter for suggesting splines for modelling time. Contribution: SSZ analysed the data and wrote the manuscript with significant input from all co- authors. GTJ is the Deputy Chief Investigator on BSRBR-AS and designed the study and oversaw its conduct. In the current project they discussed results and provided input into drafts of the manuscript. Funding: The BSRBR-AS is funded by the British Society for Rheumatology (BSR) who have received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments. They have no input in determining the topics for analysis or work involved in undertaking it.9454622engSDG 3 - Good Health and Well-beingaxial spondyloarthritisdepressionmental healthanxietytreatment responseR MedicineOtherSupplementary DataRJournal article10.1093/rheumatology/keab2426012